Medical Press Release - Page 12 of 12 - Medika Life : Keeping you informed

An international team of researchers reports in the New England Journal of Medicine dramatically transforming aPAP treatment by helping develop a drug that patients can inhale once a day so their body will clear out the pulmonary waste.

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

Medika Life - October 29, 2020

Workit Health now offers the nation’s only virtual at-home detox programs for alcohol. The program includes daily video check-ins with a medical care team and prescribed medication to safely detox at home

NLR. Millions at Risk from Leprosy. Study Reveals Figures

Medika Life - March 1, 2021

To interrupt leprosy transmission and reduce annual new cases significantly, preventive treatment needs to be implemented in all leprosy-endemic countries

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

AI-Driven Model Supports Safer and More Precise Blood Sugar Management After Heart Surgery

Corundum Convergence Institute Launches to Catalyze Funding for Research and Innovation in Neuroscience and Systems Biology

StuffThatWorks and The Marfan Foundation to Engage in Pilot Program

Intellihealth Chief Medical Officer, Dr. Leon Igel, Honored as American Diabetes Association Greater New York Research Dinner Medical Honoree of the Year

LATEST

TRENDING

Medika’s Call for Food Aid for Starving Filipino Children

Lover, the App That Helps Women Reach Orgasm

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

The 50 Most Influential Leaders in Pharmacy 2022 Awards

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

FINN Partners Brings Aboard the Pharmacy Podcast Network

South University Announces New MSPA Program at West Palm Beach Campus

Parnell Pharmaceuticals Announces Nomovid™ Antiviral Nasal Spray

EDITORS CHOICE

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

Doctors Find Drug for Lethal Lung Disease After Decades of Trying

The Nation’s Only Virtual At-Home Detox Programs from Workit Health Expands

NLR. Millions at Risk from Leprosy. Study Reveals Figures

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories